Skip to content

Research and Clinical Value of New Classification for Premature Ejaculation

Research and Clinical Value of New Classification for Premature Ejaculation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15006895
Enrollment
Unknown
Registered
2015-08-06
Start date
2015-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ejaculation

Interventions

Penile sensory hyperexcitability group:Compound Lidocaine Cream
Sympathetic hyperexcitability Group:Priligy(Dapoxetine)
Mixed type group :Compound Lidocaine Cream+Priligy(Dapoxetine)

Sponsors

Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Male aged between 18 and 60; 2. Men in stable heterosexual, monogamous relationships >6 months; 3. Symptom of PE: in recent 6 months, ejaculation that always or nearly always occurs prior to or within about 2 minute of vaginal penetration; the inability to delay ejaculation; and negative personal consequences, such as distress, bother, frustration, and/or the avoidance of sexual intimacy.

Exclusion criteria

Exclusion criteria: 1. Urinary system infection: Abnormal result of routine urine and prostatic fluid routine examination; 2. Abnormal sex hormone: Abnormal result of sex hormone examination; 3. Systemic disease: hypertension, diabetes mellitus, alcohol dependence syndrome, coronary heart disease, and Mental disorder; 4. Organic disorder: Abnormal palpation of external genitals, testis, epididymis and spermatic cord; 5. Drug influence: use of any drug for PE, e.g. SSRI , PDE-5, tramadol, etc; 6. Known drug allergy to amide-type local anaesthetics or dapoxetine; 7. Currently participating, or in the past 30 days quit a another clinical research independent with this research; 8. Drugs, alcohol or substance abuse in last 6 months; 9. moderate or more severe erectile Dysfunction.

Design outcomes

Primary

MeasureTime frame
Intravaginal ejaculation latency time;PEDT;PEP;

Countries

China

Contacts

Public ContactYutian Dai
13913957628@163.com+86 13913957628

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026